《2026年美国胃肠病学院临床指南: 肝性脑病》摘译
DOI: 10.12449/JCH260605
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:卞佳乐、韩涛负责文章翻译;韩涛负责文章审校。
-
摘要: 肝性脑病是肝硬化的重要并发症,预后差,给患者、家庭及医疗系统带来沉重负担。近年来,有关肝性脑病的诊断和管理策略已取得重要进展,但仍存在不少问题尚待解决。2026年,美国胃肠病学院发布了肝性脑病临床指南,内容涵盖肝性脑病诊断、管理和预防策略的建议,为肝性脑病诊疗提供指导。本文对该指南中的推荐意见、核心观点等内容进行摘译。Abstract: Hepatic encephalopathy (HE) is a major complication of liver cirrhosis associated with a poor prognosis, imposing a heavy burden on patients, families, and the healthcare system. In recent years, although significant advances have been made in the diagnosis and management strategies for HE, many issues remain to be resolved. In 2026, the American College of Gastroenterology released a clinical guideline on HE, covering recommendations on the diagnosis, management, and prevention of HE, which provides guidance for clinical practice. This article gives an excerpt of the recommendations and key views from this guideline.
-
Key words:
- Hepatic Encephalopathy /
- Liver Cirrhosis /
- Practice Guideline /
- United States
-
[1] BAJAJ JS, JAKAB SS, JESUDIAN AB, et al. ACG clinical guideline: Hepatic encephalopathy[J]. Am J Gastroenterol, 2026, 121( 3): 588- 618. DOI: 10.14309/ajg.0000000000003899. -
本文二维码
计量
- 文章访问数: 10
- HTML全文浏览量: 3
- PDF下载量: 1
- 被引次数: 0

PDF下载 ( 578 KB)
下载:
